Correspondence 0001104659-23-038279 from SHL TELEMEDICINE LTD (SHLT) (CIK 0001166834) (SHMLF)
SHL TELEMEDICINE LTD (SHLT) (CIK 0001166834)
Date: March 29, 2023 · CIK: 0001166834 · Accession: 0001104659-23-038279
AI Filing Summary & Sentiment
File numbers found in text: 001-41641, 333-270672
Letter
March 29, 2023
VIA EDGAR AND ELECTRONIC MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Benjamin Richie
Lauren Nguyen
Re:
SHL Telemedicine Ltd.
Registration Statement on Form 20-F (File No. 001-41641)
Ladies and Gentlemen:
Pursuant to Rule 12d1-2 promulgated under the Securities Exchange Act of 1934, as amended, SHL Telemedicine Ltd. (the “Company”) respectfully requests acceleration of the effectiveness of its Registration Statement on Form F-6 (File No. 001-41641) (the “Registration Statement”), so as to become effective at 3:00 p.m. New York time on Thursday, March 30, 2023, or as soon as possible thereafter.
The Company has been informed by the Nasdaq Capital Market (“NASDAQ”) that the NASDAQ will certify to the Commission that the Company has been approved by NASDAQ for listing.
We understand that The Bank of New York Mellon, as depositary for the Company’s American Depositary Shares, has requested that the Registration Statement on Form F-6 (File No. 333-270672) be declared effective simultaneously with the Registration Statement, and the Company concurs with that request.
Please do not hesitate to contact Scott Saks of Norton Rose Fulbright US LLP at (212) 318-3151 with any questions. Please notify Scott Saks when this request for acceleration has been granted.
Very truly yours,
By:
/s/ Erez Nachtomy
Show Raw Text
CORRESP
1
filename1.htm
March 29, 2023
VIA EDGAR AND ELECTRONIC MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Benjamin Richie
Lauren Nguyen
Re:
SHL Telemedicine Ltd.
Registration Statement on Form 20-F (File No. 001-41641)
Ladies and Gentlemen:
Pursuant to Rule 12d1-2
promulgated under the Securities Exchange Act of 1934, as amended, SHL Telemedicine Ltd. (the “Company”) respectfully requests
acceleration of the effectiveness of its Registration Statement on Form F-6 (File No. 001-41641) (the “Registration Statement”),
so as to become effective at 3:00 p.m. New York time on Thursday, March 30, 2023, or as soon as possible thereafter.
The Company has been informed
by the Nasdaq Capital Market (“NASDAQ”) that the NASDAQ will certify to the Commission that the Company has been approved
by NASDAQ for listing.
We understand that The Bank
of New York Mellon, as depositary for the Company’s American Depositary Shares, has requested that the Registration Statement on
Form F-6 (File No. 333-270672) be declared effective simultaneously with the Registration Statement, and the Company concurs
with that request.
Please do not hesitate to
contact Scott Saks of Norton Rose Fulbright US LLP at (212) 318-3151 with any questions. Please notify Scott Saks when this request for
acceleration has been granted.
Very truly yours,
By:
/s/ Erez Nachtomy
Erez Nachtomy
Chief Executive Officer